COVID-19: The Emerging Immunopathological Determinants for Recovery or Death

COVID-19: The Emerging Immunopathological Determinants for Recovery or Death

Hyperactivation of the host immune system during infection by SARS-CoV-2 is the leading cause of death in COVID-19 patients. It is also evident that patients who develop mild/moderate symptoms and successfully recover display functional and well-regulated immune response. Whereas a delayed initial i...

Full description

Bibliographic Details
Main Authors:	Tanveer Ahmad, Rituparna Chaudhuri, Mohan C. Joshi, Ahmad Almatroudi, Arshad Husain Rahmani, Syed Mansoor Ali
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Microbiology
Subjects:	COVID-19 SARS-CoV-2 lymphocytopaenia T cell response viral evasion interferon response
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2020.588409/full

Similar Items

Severe acute respiratory syndrome Coronavirus-2 infection: A synopsis of the host immune responses and viral immune evasion strategies involved
by: Bala, N. Umar, et al.
Published: (2021-04-01)

Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses
by: Ping Liu, et al.
Published: (2020-09-01)

Of Keeping and Tipping the Balance: Host Regulation and Viral Modulation of IRF3-Dependent <i>IFNB1</i> Expression
by: Hella Schwanke, et al.
Published: (2020-07-01)

Grass Carp Reovirus (GCRV) Giving Its All to Suppress IFN Production by Countering MAVS Signaling Transduction
by: Long-Feng Lu, et al.
Published: (2020-10-01)

Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
by: Desh Deepak Singh, et al.
Published: (2020-01-01)

Effect of adjuvant interferon aerosol inhalation on inflammatory response and stress response in neonatal viral pneumonia
by: Yong-Fang Zhang, et al.
Published: (2018-12-01)

Immune evasion of SARS-CoV-2 from interferon antiviral system
by: Yuan-Qin Min, et al.
Published: (2021-01-01)

Evasion of the Host Immune Response by Betaherpesviruses
by: Daniel G. Sausen, et al.
Published: (2021-07-01)

Viral Evasion of RIG-I-Like Receptor-Mediated Immunity through Dysregulation of Ubiquitination and ISGylation
by: Cindy Chiang, et al.
Published: (2021-01-01)

Activation and Evasion of Innate Antiviral Immunity by Herpes Simplex Virus
by: Søren R. Paludan, et al.
Published: (2009-11-01)

Understanding the immunopathology of SARS-CoV-2 infection - the key to successful COVID-19 therapy
by: Ewa Brzezińska-Błaszczyk, et al.
Published: (2021-04-01)

Virus Control of Cell Metabolism for Replication and Evasion of Host Immune Responses
by: María Maximina B. Moreno-Altamirano, et al.
Published: (2019-04-01)

The Role of Coronavirus RNA-Processing Enzymes in Innate Immune Evasion
by: Georgia Mandilara, et al.
Published: (2021-06-01)

Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV-monoinfected patients receiving antiviral therapy
by: Márcia Paschoal do Espírito-Santo, et al.
Published: (2013-05-01)

SARS-CoV-2 Accessory Protein ORF7b Mediates Tumor Necrosis Factor-α-Induced Apoptosis in Cells
by: Ruiping Yang, et al.
Published: (2021-08-01)

Placental Immune Responses to Viruses: Molecular and Histo-Pathologic Perspectives
by: Kavita Narang, et al.
Published: (2021-03-01)

The Immune Response and Immunopathology of COVID-19
by: Esmaeil Mortaz, et al.
Published: (2020-08-01)

COVID-19: an Immunopathological View
by: Kamran Kadkhoda
Published: (2020-04-01)

Transcriptomic analysis reveals novel mechanisms of SARS‐CoV‐2 infection in human lung cells
by: Shaomin Yang, et al.
Published: (2020-12-01)

Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity
by: Maria Vono, et al.
Published: (2021-10-01)

A model of the innate immune response to SARS-CoV-2 in the alveolar epithelium
by: R. N. Leander, et al.
Published: (2021-08-01)

Prospects of honey in fighting against COVID-19: pharmacological insights and therapeutic promises
by: Khandkar Shaharina Hossain, et al.
Published: (2020-12-01)

RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients
by: Kirsten Alexandra Eberhardt, et al.
Published: (2020-09-01)

Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2
by: Sounik Manna, et al.
Published: (2020-10-01)

Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications
by: Alessandro Allegra, et al.
Published: (2020-07-01)

Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
by: Sara Lega, et al.
Published: (2020-05-01)

Modulation of Type-I Interferon Response by hsa-miR-374b-5p During Japanese Encephalitis Virus Infection in Human Microglial Cells
by: Meghana Rastogi, et al.
Published: (2019-08-01)

Immunopathological Changes in SARS-CoV-2 Critical and Non-critical Pneumonia Patients: A Systematic Review to Determine the Cause of Co-infection
by: Saikat Samadder
Published: (2021-02-01)

Evasion of Intracellular DNA Sensing by Human Herpesviruses
by: Debipreeta Bhowmik, et al.
Published: (2021-03-01)

High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals
by: Jeremy W. Prokop, et al.
Published: (2021-07-01)

RIG-I is responsible for activation of type I interferon pathway in Seneca Valley virus-infected porcine cells to suppress viral replication
by: Pengfei Li, et al.
Published: (2018-10-01)

Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan
by: Jung-An Lin, et al.
Published: (2014-10-01)

The Interplay between Dengue Virus and the Human Innate Immune System: A Game of Hide and Seek
by: Nicolas Tremblay, et al.
Published: (2019-10-01)

Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective
by: Alaa Alnefaie, et al.
Published: (2020-11-01)

Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection
by: Pei Hua Lee, et al.
Published: (2020-01-01)

Poxviral Targeting of Interferon Regulatory Factor Activation
by: Clara Lawler, et al.
Published: (2020-10-01)

SARS-CoV-2 Proteins Exploit Host’s Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways
by: Md. Abdullah-Al-Kamran Khan, et al.
Published: (2021-01-01)

Long Non-coding RNAs: Regulators of Viral Infection and the Interferon Antiviral Response
by: Lipeng Qiu, et al.
Published: (2018-07-01)

Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response
by: Miguel Rodríguez Pulido, et al.
Published: (2017-06-01)

Interferon-Responsive Genes Are Targeted during the Establishment of Human Cytomegalovirus Latency
by: Elizabeth G. Elder, et al.
Published: (2019-12-01)